Santhera Pharmaceuticals Holding AG announced the appointment of Shabir Hasham, MD,as Chief Medical Officer (CMO) and a member of Santhera's Executive Management team, effective May 1, 2022. Shabir has served as Santhera's Global Development Program Lead & Global Head Medical Affairs for the past three years. He previously served as Santhera's Head of Medical Affairs EU & RoW.

Before joining Santhera in 2015, Shabir held various positions at Novartis including EU Medical Director and Global Associate Brand Director for the Neuroscience franchise at Novartis Pharma, and Senior Medical Manager at Novartis Oncology, contributing to global and regional clinical development, medical affairs and launch plans for new products. Earlier in his career, Shabir held medical manager and advisor roles within the neuroscience franchise at Biogen Idec and Pfizer's cardiovascular business.